Actively Recruiting
Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients
Led by Ajou University School of Medicine · Updated on 2026-04-13
45
Participants Needed
4
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn whether a mobile-based personalized physical activity program called SuperBrain BOOM is safe and works to improve cognitive function, physical performance, mood, and quality of life in older adults (ages 50-85) with mild cognitive impairment (MCI). The main questions it aims to answer are: Can SuperBrain BOOM be safely and effectively used by people with MCI? Does the program help improve cognitive and physical function? Do participants stay engaged and complete the program as expected? Researchers will compare: A mobile intervention group using SuperBrain BOOM (on tablet or smartphone) A control group receiving usual care Participants will: Use a tablet or smartphone to follow a personalized physical activity program for 12 weeks Complete clinical assessments on cognition, physical ability, mood, and nutrition Be monitored for safety and program adherence using automatically collected data
CONDITIONS
Official Title
Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 50 and 85 years old
- Meets core clinical criteria for suspected Mild Cognitive Impairment (MCI) per NIA-AA guidelines
- Concerns about cognitive decline from participant or caregiver
- Impairment in at least one cognitive domain
- Preserved independence in daily living activities
- No dementia diagnosis
- At least one qualifying neuropsychological test result within one year showing delayed recall below -1.0 SD
- Korea-Mini Mental State Examination score at least -1.5 SD below mean
- Global Clinical Dementia Rating score of 0.5 with memory score 0.5 or 1
- Capable of using a tablet or smartphone, or has a research partner to assist
- Has a caregiver who supports and monitors, spending at least 8 hours per week
- Provides written informed consent to participate
You will not qualify if you...
- Presence of psychiatric disorders such as major depression
- Dementia diagnosis
- Other neurodegenerative diseases like Parkinson's disease
- Malignant tumors in past 5 years not declared cured
- Vascular surgery or stent placement within past year
- Severe or unstable cardiovascular disease
- Severe or unstable physical conditions interfering with trial completion
- Severe vision or hearing impairment or communication difficulties
- Abnormal clinical pathology related to cognitive decline (e.g., thyroid dysfunction, vitamin deficiencies, neurosyphilis)
- Investigator judges participant unlikely to cooperate fully
- Investigator judges participant unsafe for exercise-based program
- Participation in another interventional clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Bundang CHA General Hospital
Seongnam-si, Gyeonggi-do, South Korea
Actively Recruiting
2
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea, 16499
Actively Recruiting
3
Pusan National University Hospital
Busan, South Korea
Actively Recruiting
4
Chonnam National University Hospital
Gwangju, South Korea
Actively Recruiting
Research Team
K
Kyunghwa Sun
CONTACT
D
Daae Kim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here